CAR T at UCLA - Driving the Progress of Engineered Cell Therapy

CAR T at UCLA - Driving the Progress of Engineered Cell Therapy

Explore the groundbreaking CAR T cell therapy for lymphoma in this informative talk by UCLA hematologist Dr. Sarah Larson. Delve into the latest research aimed at enhancing the safety and efficacy of this promising therapeutic approach. Gain insights into CAR T targets, antigen escape, stem cells, and safety considerations. Learn about the Leukemia Lymphoma Society and the Climb to Cure initiative. Discover how engineered cell therapy is advancing cancer treatment at UCLA and participate in a Q&A session to deepen your understanding of this cutting-edge medical breakthrough.